Schedule 13G ownership disclosure

AGILE THERAPEUTICS INC

Security class unavailable · CUSIP: 00847L209

Event date: 2022-07-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,430,345
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-038363
Form type
SC 13G
Filer
AGILE THERAPEUTICS INC
CIK
CIK 1261249
Filed
Jul 11, 2022
Reporting period
Jul 01, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub